Northwest Biotherapeutics reported $-10.9M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Agenus USD 15.05M 656K Mar/2026
AstraZeneca USD 4.66B 1.5B Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Celldex Therapeutics USD -80.62M 3.81M Jun/2026
Eisai JPY 16.7B 8.03B Sep/2026
Merck USD 7.33B 6.49B Sep/2026
Northwest Biotherapeutics USD -10.9M 3.42M Mar/2026
Pfizer USD 4.85B 5.03B Sep/2026
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Roche Holding CHF 11.46B 1.91B Jun/2026